. Author manuscript; available in PMC: 2022 Jan 1.

Published in final edited form as: Gynecol Oncol. 2020 Nov 4;160(1):99–105. doi: 10.1016/j.ygyno.2020.10.020

Table 2:

Recurrence Patterns

	Total Cohort	Non-morcellated	Morcellation
Recurrence Type	110	72	38
Hematogenous	61(55.5%)	50(69.4%)	11(28.9%)
Peritoneal	37(33.6%)	13(18.1%)	24(63.2%)
Retroperitoneal	2(1.8%)	2(2.8%)	0(0%)
Hematogenous + Peritoneal	9(8.2%)	7(9.7%)	2(5.3%)
Hematogenous + Peritoneal + Retroperitoneal	1(0.9%)	0(0%)	1(2.6%)